-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Hepion Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2014 to 2024.
- Hepion Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$2.97M.
- Hepion Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$3.38M, a 17.1% decline year-over-year.
- Hepion Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was -$2.97M, a 626% decline from 2023.
- Hepion Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$409K, a 85.8% increase from 2022.
- Hepion Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.88M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)